Excessive alcohol consumption can result in alcoholic liver disease (ALD). There is no FDA-approved drug to specifically treat ALD and current management approaches have limited efficacy. Past studies indicate that monoacylglycerol lipase (MAGL) inhibition can have a positive impact on nonalcoholic fatty liver disease. However, the effect of MAGL inhibition in ALD has not been reported.
Materials and Methods:
We tested the highly selective and clinically evaluated MAGL inhibitor ABX-1431 in the Lieber-DeCarli liquid alcohol diet-induced model of ALD in C57BL/6 mice.
Results:
ABX-1431 failed to reduce ALD-associated steatosis and elevated levels of liver enzymes associated with hepatic injury. Furthermore, survival rate declined with increasing doses of ABX-1431 when compared with mice administered vehicle only.
Conclusion:
These data suggest that MAGL inhibition does not improve ALD and is unlikely to be a good strategy for this condition.
Get full access to this article
View all access options for this article.
References
1.
WongT, DangK, LadhaniS, et al.Prevalence of alcoholic fatty liver disease among adults in the United States, 2001–2016. JAMA, 2019; 321(17):1723–1725; doi: 10.1001/jama.2019.2276
2.
TermeieO, FiedlerL, MartinezL, et al.Alarming trends: Mortality from alcoholic cirrhosis in the United States. Am J Med, 2022; 135(10):1263–1266; doi: 10.1016/j.amjmed.2022.05.015
3.
LieberCS. Alcoholic liver disease: new insights in pathogenesis lead to new treatments. J Hepatol, 2000; 32(1 Suppl):113–128; doi: 10.1016/s0168-8278(00)80420-1
4.
Alves-BezerraM, CohenDE. Triglyceride metabolism in the liver. Compr Physiol, 2017; 8(1):1–8; doi: 10.1002/cphy.c170012
5.
OsnaNA, DonohueTMJr., KharbandaKK. Alcoholic liver disease: Pathogenesis and current management. Alcohol Res, 2017; 38(2):147–161.
ThomesPG, OsnaNA, DavisJS, et al.Cellular steatosis in ethanol oxidizing-HepG2 cells is partially controlled by the transcription factor, early growth response-1. Int J Biochem Cell Biol, 2013; 45(2):454–463; doi: 10.1016/j.biocel.2012.10.002
PinterM, TraunerM, Peck-RadosavljevicM, et al.Cancer and liver cirrhosis: Implications on prognosis and management. ESMO Open, 2016; 1(2):e000042; doi: 10.1136/esmoopen-2016-000042
12.
QuirogaAD, LehnerR. Pharmacological intervention of liver triacylglycerol lipolysis: The good, the bad and the ugly. Biochem Pharmacol, 2018; 155:233–241; doi: 10.1016/j.bcp.2018.07.005
13.
DinhTP, CarpenterD, LeslieFM, et al.Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A, 2002; 99(16):10819–10824; doi: 10.1073/pnas.152334899
14.
NomuraDK, MorrisonBE, BlankmanJL, et al.Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science, 2011; 334(6057):809–813; doi: 10.1126/science.1209200
15.
LongJZ, LiW, BookerL, et al.Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Biol, 2009; 5(1):37–44; doi: 10.1038/nchembio.129
16.
HabibA, ChokrD, WanJ, et al.Inhibition of monoacylglycerol lipase, an anti-inflammatory and antifibrogenic strategy in the liver. Gut, 2019; 68(3):522–532; doi: 10.1136/gutjnl-2018-316137
17.
CaoZ, MulvihillMM, MukhopadhyayP, et al.Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice. Gastroenterology, 2013; 144(4):808–817.e15; doi: 10.1053/j.gastro.2012.12.028
18.
TardelliM, BruschiFV, FuchsCD, et al.Monoacylglycerol lipase inhibition protects from liver injury in mouse models of sclerosing cholangitis. Hepatology, 2020; 71(5):1750–1765; doi: 10.1002/hep.30929
19.
CisarJS, WeberOD, ClapperJR, et al.Identification of ABX-1431, a selective inhibitor of monoacylglycerol lipase and clinical candidate for treatment of neurological disorders. J Med Chem, 2018; 61(20):9062–9084; doi: 10.1021/acs.jmedchem.8b00951
20.
FulhamMA, MandrekarP. Sexual dimorphism in alcohol induced adipose inflammation relates to liver injury. PLoS One, 2016; 11(10):e0164225; doi: 10.1371/journal.pone.0164225
21.
IimuroY, FrankenbergMV, ArteelGE, et al.Female rats exhibit greater susceptibility to early alcohol-induced liver injury than males. Am J Physiol, 1997; 272(5 Pt 1):G1186–G1194; doi: 10.1152/ajpgi.1997.272.5.G1186
22.
MaddurH, ShahVH. Alcohol and liver function in women. Alcohol Res, 2020; 40(2):10; doi: 10.35946/arcr.v40.2.10
23.
TardelliM, BruschiFV, ClaudelT, et al.Lack of monoacylglycerol lipase prevents hepatic steatosis by favoring lipid storage in adipose tissue and intestinal malabsorption. J Lipid Res, 2019; 60(7):1284–1292; doi: 10.1194/jlr.M093369
24.
AndersonLL, DoohanPT, HawkinsNA, et al.The endocannabinoid system impacts seizures in a mouse model of Dravet syndrome. Neuropharmacology, 2022; 205:108897; doi: 10.1016/j.neuropharm.2021.108897
